VANCOUVER, Sept. 4 /CNW/ - Burcon NutraScience Corporation (TSX - BU)
("Burcon" or the "Corporation") is pleased to announce the appointment of Dr.
Lawrence Wang to its board of directors.
After an extensive teaching and research career, Dr. Wang retired in 2005
and became Professor Emeritus in the Department of Biological Sciences at the
University of Alberta. Dr. Wang undertook his graduate studies in the United
States and finished his Masters degree in Biology at Rice University, Houston,
Texas, and his Ph. D. degree in Animal Physiology at Cornell University in
Ithaca, New York in the 1960's.
Dr. Wang's research involved energy and fat metabolism and the
enhancement of cold tolerance in man, hibernation and hypothermia, and the
influence of herbs (e.g. ginseng) on learning and memory, aging, exercise, and
obesity. His publications include five patents, five edited books, and over
150 original scientific research papers and reviews. He is the inventor of the
Canadian Cold Buster bar and the Access bar, a patented,
technology-transferred product based on his 18 years of research on energy and
fat metabolism. This "fat-conversion activity bar" is currently being marketed
in the US, Canada, Australia, New Zealand, Taiwan, Hong Kong, Korea and the
Throughout his career, Dr. Wang has received numerous awards including
the Innovative Technology of the Year, Alberta Science and Technology
Leadership Award (1992), the Gordon Royal Maybee Award from the Canadian
Institute of Food Science and Technology (1992), Elected Fellow, Academy of
Sciences, Royal Society of Canada (FRSC, 1993), the highest honor achievable
by any academics in Canada and the Friendship Award, Government of China, for
service to eco-rehabilitation and poverty alleviation in rural China (2006) to
name a few.
In 2000, Dr. Wang Co-Founded the University of Alberta's ECO (Ecological
Conservancy Outreach) Fund. The main objective of the ECO Fund is to help with
eco-rehabilitation and eco-management of the Upper Yangtze River. In addition
to funding, Dr. Wang and the scientists at the University of Alberta have also
provided technical and socio-economic expertise to help with fourteen on-going
ECO projects in China.
Throughout the years, Dr. Wang has held Visiting and Honorary
Professorships in several prestigious academic institutions in China: Peking
Union Medical College, Peking University, Qingdao Medical College, Mudangjiang
Medical College, Xinjiang Medical College, and Jinan Medical College. He is
also actively involved in local community services. He has served as a Board
member of the "Odyssium" (The Telus World of Science) a non-profit Foundation
in Edmonton, Alberta aiming to promote science and technology to school
children and the general public.
Dr. Allan Yap, Chairman and Chief Executive Officer of Burcon said, "Dr.
Wang's experience and knowledge in the field on human metabolism will be an
asset to Burcon as we continue to study the potential benefits of adding
Burcon's Puratein(R), Supertein(TM) and CLARISOY(TM) to the human diet. We are
excited to have Dr. Wang join our board of directors."
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of
functional, renewable plant proteins. Since 1999, Burcon has developed a
portfolio of composition, application, and process patents originating from
our core protein extraction and purification technology. We are developing the
world's first commercial canola proteins, Puratein(R) and Supertein(TM) with
unique functional and nutritional attributes, and CLARISOY(TM), a
revolutionary soy protein isolate which is 100% soluble and completely
transparent in acidic solutions. Our team of highly specialized scientists and
engineers work from our own research facility to develop and optimize
environmentally sound technologies. To-date, our patent portfolio consists of
90 issued patents in various countries, including 8 issued U.S. patents, and
in excess of 200 additional pending patent applications, 65 of which are U.S.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
Burcon NutraScience Corporation is a publicly listed on the Toronto Stock
Exchange under the symbol "BU". For more information on Burcon, visit
This press release contains forward-looking statements that involve risks
and uncertainties. These forward-looking statements relate to, among other
things, the Corporation's, plans and timing for the introduction or
enhancement of our products, statements about future market conditions, supply
and demand conditions, and other expectations, intentions and plans contained
in this press release that are not historical fact. Our expectations regarding
the prospect for future success depend upon our ability to develop and sell
products, which we do not produce today and cannot be sold without further
research and development. When used in this press release, the words "goal",
"intend", "believes", "potential", "expected", "anticipates", "will be", and
similar expressions, generally identify forward- looking statements. These
statements reflect our current expectations. They are subject to a number of
risks and uncertainties. In light of the many risks and uncertainties
surrounding the development of a source of protein from canola meal, you
should understand that we cannot assure you that the forward looking
statements contained in this press release will be realized.
For further information:
For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free,
email@example.com, www.burcon.ca; AXINO AG, Wolfgang Seybold, Investor
Relations Europe, AXINO AG, Konigstrasse 26, 70173, Stuttgart, Germany, Tel.
+49-711-25 35 92-40, Fax +49-711-25 35 92-55, firstname.lastname@example.org,